Skip to content

Debt-to-assets at other companies

Eli Lilly logo
Eli LillyLLY
0.4×-0.1×
Pfizer logo
PfizerPFE
0.3×0.0×
Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
0.1×0.0×
Collegium Pharmaceutical, Inc. logo
Collegium Pharmaceutical, Inc.COLL
0.0×
Bioventus logo
BioventusBVS
0.4×-0.1×
Avanos Medical logo
Avanos MedicalAVNS
0.1×0.0×

Other financials

Income statement

See full
Operating income-$5.1M-14.6%
Net income-$5.0M+54.4%
EPS (diluted)-$0.15+98.2%

Balance sheet

See full
Cash & equivalents$13.2M-24.6%
Total debt$144.9K-24.2%
Total equity$80.6M+1,038%
Total assets$95.2M-1.8%

Cash flow

See full
Operating cash flow-$4.6M+2.0%

Valuation

See full
Market cap$54.14M-57.6%
Enterprise value$41.06M-64.7%

Returns & leverage

See full
Return on equity-64.6%-29.8pp
Debt / equity0.0×
Current ratio5.9×-1.6×

Where this comes from

Calculated from Dogwood Therapeutics’s reported figures.

Based on the most recent quarter.

The official record: Dogwood Therapeutics’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Dogwood Therapeutics's debt-to-assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Dogwood Therapeutics's debt-to-assets?
Dogwood Therapeutics (DWTX) reported debt-to-assets of 0× in Q1 2026.
How has Dogwood Therapeutics's debt-to-assets changed year-over-year?
Dogwood Therapeutics's debt-to-assets decreased by 25.0% year-over-year, from 0× to 0×.
What does debt-to-assets mean?
Total debt divided by total assets at the quarter end. Measures the share of the asset base financed by debt.